史达手术

最新新闻

• 评级变动
  A Quick Look at Today's Ratings for Staar Surgical(STAA.US), With a Forecast Between $32 to $33
  \u5e02\u573a\u8d44\u8baf · 2026/7/17
• 评级变动
  Needham Maintains Staar Surgical(STAA.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 评级变动
  CCORF Maintains Staar Surgical(STAA.US) With Hold Rating, Raises Target Price to $30.75
  \u5e02\u573a\u8d44\u8baf · 2025/12/10
• 评级变动
  Morgan Stanley Maintains Staar Surgical(STAA.US) With Sell Rating, Maintains Target Price $13
  \u5e02\u573a\u8d44\u8baf · 2026/3/11
• Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Maintains Target Price $31
  \u5e02\u573a\u8d44\u8baf · 2026/9/29
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA), Nephros (NEPH) and Acrivon Therapeutics, Inc. (ACRV)
  TipRanks · 2026/8/13
• 评级变动
  CCORF Maintains Staar Surgical(STAA.US) With Hold Rating, Cuts Target Price to $22
  \u5e02\u573a\u8d44\u8baf · 2026/1/16
• Jefferies Initiates Staar Surgical(STAA.US) With Hold Rating, Announces Target Price $23
  \u5e02\u573a\u8d44\u8baf · 2026/9/22
• 评级变动
  Wedbush Maintains Staar Surgical(STAA.US) With Buy Rating, Maintains Target Price $40
  \u5e02\u573a\u8d44\u8baf · 2026/7/21
• 评级变动
  Wedbush Initiates Staar Surgical(STAA.US) With Hold Rating, Announces Target Price $26
  \u5e02\u573a\u8d44\u8baf · 2026/4/9
• 评级变动
  Stifel Maintains Staar Surgical(STAA.US) With Hold Rating, Cuts Target Price to $19
  \u5e02\u573a\u8d44\u8baf · 2026/2/9
• Stifel Upgrades Staar Surgical(STAA.US) to Buy Rating, Raises Target Price to $31
  \u5e02\u573a\u8d44\u8baf · 2026/9/29
• 评级变动
  BTIG Maintains Staar Surgical(STAA.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/3/10
• 评级变动
  CCORF Maintains Staar Surgical(STAA.US) With Hold Rating, Maintains Target Price $30.75
  \u5e02\u573a\u8d44\u8baf · 2026/1/7
• 评级变动
  A Quick Look at Today's Ratings for Staar Surgical(STAA.US), With a Forecast Between $31 to $40
  \u5e02\u573a\u8d44\u8baf · 2026/5/15
• Stifel Maintains Staar Surgical(STAA.US) With Hold Rating, Cuts Target Price to $28
  \u5e02\u573a\u8d44\u8baf · 2026/8/17
• 评级变动
  Piper Sandler Maintains Staar Surgical(STAA.US) With Hold Rating, Maintains Target Price $33
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 评级变动
  CCORF Maintains Staar Surgical(STAA.US) With Hold Rating, Maintains Target Price $22
  \u5e02\u573a\u8d44\u8baf · 2026/3/5
• 评级变动
  Mizuho Securities Maintains Staar Surgical(STAA.US) With Hold Rating, Raises Target Price to $22
  \u5e02\u573a\u8d44\u8baf · 2026/3/5
• SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of STAAR Surgical Company (NASDAQ: STAA).
  PR Newswire · 2026/9/24

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。